Skip to content

Driving Simulator Study Comparing Two Modes of Presbyopic Correction With Contact Lenses

Driving Simulator Study Comparing Two Modes of Presbyopic Correction With Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02189863
Enrollment
33
Registered
2014-07-15
Start date
2014-08-31
Completion date
2014-12-31
Last updated
2016-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Presbyopia

Keywords

Driving Simulator, Air Optix Aqua, AOAMF

Brief summary

The overall objective of this study is to compare the effect on simulated driving performance of multifocal (MF) versus monovision (MV) soft contact lenses in mid-late presbyopes.

Detailed description

In this crossover study, subjects wore lotrafilcon B MV (AOAMV) and lotrafilcon B MF (AOAMF) soft contact lenses as randomized for 2 weeks each. Subjects were assessed using a standardised driving simulation for each of the two treatments. A fresh pair of lenses was dispensed for the assessment. Subjects also wore lotrafilcon B single vision distance (SVD) and comfilcon A MF contact lenses during Period 1 and Period 2 respectively for an additional same-day assessment. Habitual correction was worn for an acclimatization drive in the driving simulator during Period 1.

Interventions

DEVICELotrafilcon B MF

Multifocal contact lenses worn in both eyes

DEVICELotrafilcon B MV

Spherical contact lenses worn with 1 eye corrected for distance and 1 eye corrected for near

DEVICELotrafilcon B SVD

Spherical contact lenses worn with both eyes corrected for distance

DEVICEComfilcon A MF

Multifocal contact lenses worn in both eyes

Contact lenses worn in both eyes per subject's habitual prescription

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
No minimum to 70 Years
Healthy volunteers
No

Inclusion criteria

* Current soft contact lens wearers (for 1 month or more) with distance spherical power requirements of +1.00 to + 4.00 diopters (D) or -1.00 to -10.00D, and who have never tried and then failed in monovision or AOAMF. * Medium to high presbyopia, i.e. spectacle add requirement of +1.50D or more. * Astigmatism, if present, ≤1.00D in both eyes. * Distance visual acuity (VA) correctable to 20/30 (+0.2 logMAR) in both eyes. * Within the normal ranges for binocular vision for distance (8Δ exophoria, ≤8Δ esophoria), vertical phoria = 1.5Δ hypo or hyper. * Full United Kingdom driving license held for at least 3 years, with at least 2000 miles driven per year. * Willing to wear study lenses at least 5 days per week. * Other protocol-defined inclusion criteria may apply.

Exclusion criteria

* Existing AIR OPTIX® Multifocal CL user. * Sphere requirement in the range +0.75 to -0.75D in both eyes. * Previous refractive surgery. * Ocular/systemic medical condition or medical treatment contra-indicating contact lens wear or driving simulation. * Participation in a clinical study within the past 30 days. * Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
Driving Reaction Time to Hazards (as Measured by Time to Brake, in Seconds)Week 2, each periodDriving reaction time to hazards was assessed during simulated night time driving and measured as time to brake, in seconds. One eye (study eye) contributed to the analysis. This outcome measure was prespecified for AOAMV and AOAMF.

Secondary

MeasureTime frameDescription
Standard Deviation of Lateral PositioningWeek 2, each periodThe standard deviation of lateral positioning (staying in the lane) was assessed during simulated night time driving and measured as the distance of deviation from the reference point, in meters. This outcome measure is prespecified for AOAMV and AOAMF.

Participant flow

Recruitment details

Subjects were recruited from 2 investigational sites located in the UK.

Pre-assignment details

Of the 33 enrolled, 6 participants were exited as screen failures prior to randomization. This reporting group includes all randomized participants who successfully tried at least one study lens (27).

Participants by arm

ArmCount
Overall
Lotrafilcon B MV and lotrafilcon B MF contact lenses worn in Period 1 and Period 2, as randomized
27
Total27

Withdrawals & dropouts

PeriodReasonFG000FG001
First 2 WeeksMotion Sickness42

Baseline characteristics

CharacteristicOverall
Age, Continuous55.4 years
STANDARD_DEVIATION 5.4
Sex: Female, Male
Female
17 Participants
Sex: Female, Male
Male
10 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —— / —
other
Total, other adverse events
1 / 251 / 232 / 230 / 212 / 27
serious
Total, serious adverse events
0 / 250 / 230 / 230 / 210 / 27

Outcome results

Primary

Driving Reaction Time to Hazards (as Measured by Time to Brake, in Seconds)

Driving reaction time to hazards was assessed during simulated night time driving and measured as time to brake, in seconds. One eye (study eye) contributed to the analysis. This outcome measure was prespecified for AOAMV and AOAMF.

Time frame: Week 2, each period

Population: This analysis population includes all randomized subjects in the groups to which they were randomly assigned who successfully completed both study lens follow-up evaluations without a protocol deviation that was documented as impacting the assessment of the hypotheses (Per-Protocol).

ArmMeasureValue (MEAN)Dispersion
AOAMVDriving Reaction Time to Hazards (as Measured by Time to Brake, in Seconds)1.89 secondsStandard Deviation 0.22
AOAMFDriving Reaction Time to Hazards (as Measured by Time to Brake, in Seconds)1.88 secondsStandard Deviation 0.19
Secondary

Standard Deviation of Lateral Positioning

The standard deviation of lateral positioning (staying in the lane) was assessed during simulated night time driving and measured as the distance of deviation from the reference point, in meters. This outcome measure is prespecified for AOAMV and AOAMF.

Time frame: Week 2, each period

Population: This analysis population includes all randomized subjects in the groups to which they were randomly assigned who successfully completed both study lens follow-up evaluations without a protocol deviation that was documented as impacting the assessment of the hypotheses (Per-Protocol).

ArmMeasureValue (MEAN)Dispersion
AOAMVStandard Deviation of Lateral Positioning0.35 metersStandard Deviation 0.06
AOAMFStandard Deviation of Lateral Positioning0.35 metersStandard Deviation 0.05

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026